Position in IDXX
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$1,242,924
-$924,847 QoQ
Shares Held
2,361
-38.8% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#589
of 1,279 holders
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IDXX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026NORDEN GROUP LLC holds $3,533,170 across 7 Diagnostics & Research names. IDXX ranks #1 (35.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IDXX |
Idexx Laboratories Inc /De
This page
|
2,361 | $1,242,924 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
1,257 | $630,209 | |
| 3 | LH |
Labcorp Holdings Inc.
|
2,079 | $582,120 | |
| 4 | MEDP |
Medpace Holdings, Inc.
|
824 | $436,382 | |
| 5 | GH |
Guardant Health, Inc.
|
2,505 | $375,825 | |
| 6 | DHR |
Danaher Corp /De/
|
1,081 | $205,908 | |
| 7 | ADPT |
Adaptive Biotechnologies Corp
|
2,788 | $59,802 |
All Filings in IDXX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,242,924 | 2,361 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $2,167,771 | 3,858 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $2,744,005 | 4,056 | Shares | Sole | 2026-01-13 | |
| 2025-09-30 | $2,464,198 | 3,857 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $2,082,608 | 3,883 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $239,371 | 570 | Shares | Sole | 2025-05-07 | |
| 2024-09-30 | $296,058 | 586 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $202,675 | 416 | Shares | Sole | 2024-08-06 | |
| No filing history on record for this holder in this stock. | ||||||